LevOss is developing a biodegradable material (polymer) embedded with a Nano mesh.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Copenhagen
State: Hovedstaden
Zip:
Country: Denmark
The most common treatment of bone defects involves the use of autograft suffering from co-morbidity and the need for two operations. Others include allografts and alloplastics, but none have succesfully built longterm functional bone in vivo. Current treatment options for severe articular cartilage injuries are expensive, lengthy, palliative in nature, and result in generation of fibrous cartilage, which is ill adapted to the mechanical forces within a large joint, such as the knee. The LevOss scaffolds for bone and cartilage target a clearly defined market for spinal fusion surgery and for grade III/IV cartilage injuries with an increasing demand for better solutions and few competitors.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2014 | Venture Round | 1 | - |
Seed Capital Seed Capital |
1/2014 | Venture Round | 1 | - |
Seed Capital Seed Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|